Welcome

World Pharma News is an ambitious online news service dedicated to the world pharmaceutical industry. Our main goal is to keep our readers informed about the latest worldwide pharmaceutical news, realizations and achievements.

Register now to be in touch with our last developments and achievements or Subscribe to World Pharma News alerts by Email (a free service delivered by FeedBurner). Syndicated Content Powered by FeedBurner

Non progredi est regredi.

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]

Sponsored Ads

Advertisement
Google Groups
Get all news digests delivered to your inbox, subscribe to World Pharma News Google Group.
Email:

Our RSS News Channels

Sponsored Ads

Research & Development News Channel
Nature Publishing Group and Sermo partner to help physicians
Friday, 18 January 2008
Nature Publishing Group (NPG) and Sermo, the largest online physician community in the US, announced a partnership to facilitate the discussion and interpretation of content in leading NPG medical journals by US physicians.
Read more...
 
New Online Social Network, BioMedExperts, to Improve Collaboration Among Medical Researchers
Monday, 14 January 2008
Collexis Holdings, Inc. (OTCBB: CLXS), a leading developer of high definition search and knowledge discovery software, announced the debut of BioMedExperts - the first online social network of its kind to improve collaboration among researchers and therefore advance medical science. Collexis launched the new service with more than 1.4 million pre-generated profiles of its expected users from across 120 countries and expects to grow by another two million profiles over the next few months.
Read more...
 
EU Pharmacovigilance Strategy: Public consultation on draft legislative proposals
Thursday, 03 January 2008
EUDG Enterprise and Industry wishes to consult stakeholders on legislative proposals to strengthen and rationalise the EU system of pharmacovigilance. The Commission services conducted a previous consultation, between 16 March 2006 and 12 May 2006, which sought stakeholders' views on the strengths and weaknesses of the current EU system of pharmacovigilance and how the system could be strengthened.
Read more...
 
The Largest Pharmaceutical Companies and Britain's Serious Fraud Office in the News
Wednesday, 02 January 2008
Oil-for-food: UK probe to cover more companies
A UK government probe into whether GlaxoSmithKline, AstraZeneca and Eli Lilly & Co bribed the Saddam Hussein administration in Iraq may expand to other...

British ask Lilly for data on Iraq sales
British fraud investigators are questioning Eli Lilly and Co. and at least two other drug makers about possible kickbacks they paid to trade...

UK pulls Glaxo into Iraq fraud probe
Serious Fraud Office has requested documents from GlaxoSmithKline as part of an investigation into kickbacks or bribes that may have...

Read more...
 
Transinsight's GoPubMed with Social Networking Features for Biomedical Experts
Wednesday, 26 December 2007
Biomedical research happens in networks of researchers. Social networking web sites like FaceBook, LinkedIn and Xing use personal networks to establish contacts. On these sites, however, connections must be defined by the users themselves. For the first time, GoPubMed now completely and automatically extracts collaboration networks from millions of biomedical science publications.
Read more...
 
EMEA concludes new advice to doctors and patients for Champix needed
Monday, 17 December 2007
The European Medicines Agency (EMEA)The European Medicines Agency (EMEA) has concluded that updated warnings to doctors and patients are needed to increase awareness of cases of suicidal ideation and suicide attempts reported in patients using Champix (varenicline), a medicine indicated for smoking cessation in adults.
Read more...
 
EMEA recommends withdrawal of the marketing authorisations for lumiracoxib-containing medicines
Friday, 14 December 2007
The European Medicines Agency (EMEA)The European Medicines Agency (EMEA) has recommended the withdrawal of the marketing authorisations for all lumiracoxib-containing medicines, because of the risk of serious side effects affecting the liver. Lumiracoxib is a non-steroidal anti-inflammatory drug (NSAID) that belongs to the group 'COX-2 inhibitors'. It is used for symptomatic relief in the treatment of osteoarthritis of the hip and knee.
Read more...
 
5. In the Absence of Direct-to-Consumer Advertising, Online Content Is Critical
Wednesday, 12 December 2007
Manhattan Research, LLCEuropean consumers have been a longneglected piece of the strategic puzzle for most marketers at health and pharmaceutical companies. Yet, signs increasingly point to the degree to which European consumers are, in fact, researching health information and treatment options, and ultimately taking action as a result of those information searches - as outlined in the trend above.
Read more...
 
4. Empowered European Consumers Speak with Their Physician about Information Found Online
Wednesday, 12 December 2007
Manhattan Research, LLCThe Internet's role is increasing in the patient-physician relationship and having an impact on which treatment decisions are being implemented. Still, the physician clearly remains the ultimate voice on this front. Be they the "cyberchondriacs" or the "cyber savvy," consumers in Europe are turning to the Internet for self-education, symptom checking, prescription medication comparisons, and disease education.
Read more...
 
3. Online Physician Portals Evolve into Clinical Resources, Beyond News
Wednesday, 12 December 2007
Manhattan Research, LLCTraditionally, physicians relied primarily on local content sources for online medical information, such as DiarioMedico in Spain and Doctors.net in the UK. One notable exception of a site that has transcended the country divides has been the Univadis portal from MSD (Merck Sharp & Dohme).
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Results 71 - 80 of 124
Submit to World Pharma News .net

Sponsored Ads